New hope for kids with dangerous potassium levels

NCT ID NCT03813407

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 34 times

Summary

This study tests a drug called sodium zirconium cyclosilicate (SZC) to safely lower high potassium levels in children under 18. About 140 kids will receive the drug for up to 3 days to correct potassium levels, then continue for 28 days to maintain normal levels, with an option for longer treatment. The goal is to see if SZC works and is safe for children, as it already works in adults.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Birmingham, Alabama, 35233, United States
Research Site
WITHDRAWN

Atlanta, Georgia, 30322, United States
Research Site
RECRUITING

Baltimore, Maryland, 21287, United States
Research Site
WITHDRAWN

Grand Rapids, Michigan, 49503, United States
Research Site
WITHDRAWN

St Louis, Missouri, 63104, United States
Research Site
COMPLETED

Hackensack, New Jersey, 07601, United States
Research Site
WITHDRAWN

New York, New York, 10029, United States
Research Site
WITHDRAWN

Stony Brook, New York, 11794, United States
Research Site
WITHDRAWN

Charlotte, North Carolina, 28207, United States
Research Site
WITHDRAWN

Winston-Salem, North Carolina, 27157, United States
Research Site
COMPLETED

Akron, Ohio, 44308, United States
Research Site
RECRUITING

Cincinnati, Ohio, 45229, United States
Research Site
RECRUITING

Columbia, South Carolina, 29203, United States
Research Site
WITHDRAWN

Morgantown, West Virginia, 26506-7900, United States
Research Site
RECRUITING

Campinas, 13060-904, Brazil
Research Site
RECRUITING

São Paulo, 01228-200, Brazil
Research Site
RECRUITING

São Paulo, 04038-002, Brazil
Research Site
RECRUITING

Calgary, Alberta, T3B 6A8, Canada
Research Site
WITHDRAWN

Edmonton, Alberta, T6G 1C9, Canada
Research Site
WITHDRAWN

Vancouver, British Columbia, V6H 3N1, Canada
Research Site
RECRUITING

Montreal, Quebec, H3T1C5, Canada
Research Site
RECRUITING

Beijing, 100034, China
Research Site
RECRUITING

Beijing, 100045, China
Research Site
RECRUITING

Changsha, 410007, China
Research Site
RECRUITING

Chengdu, 610000, China
Research Site
RECRUITING

Chengdu, 610041, China
Research Site
RECRUITING

Chongqing, 400014, China
Research Site
RECRUITING

Hangzhou, 310052, China
Research Site
WITHDRAWN

Hefei, 230001, China
Research Site
RECRUITING

Shanghai, 200062, China
Research Site
RECRUITING

Shanghai, 201102, China
Research Site
WITHDRAWN

Berlin, D-13353, Germany
Research Site
RECRUITING

Essen, 45147, Germany
Research Site
RECRUITING

Heidelberg, 69120, Germany
Research Site
RECRUITING

Bhubaneswar, 751019, India
Research Site
NOT_YET_RECRUITING

Gurgaon, 122001, India
Research Site
WITHDRAWN

New Delhi, 110060, India
Research Site
RECRUITING

Bunkyō City, 113-8431, Japan
Research Site
WITHDRAWN

Fuchu-shi, 183-8561, Japan
Research Site
WITHDRAWN

Fukuoka, 813-0017, Japan
Research Site
WITHDRAWN

Kawasaki-shi, 211-0063, Japan
Research Site
WITHDRAWN

Kobe, 650-0047, Japan
Research Site
WITHDRAWN

Matsumoto-shi, 390-8621, Japan
Research Site
RECRUITING

Nakagami-gun, 903-0215, Japan
Research Site
WITHDRAWN

Saitama-Shi, 330-8777, Japan
Research Site
WITHDRAWN

Sendai, 989-3126, Japan
Research Site
RECRUITING

Shinjuku-ku, 162-8666, Japan
Research Site
RECRUITING

Shizuoka, 420-8660, Japan
Research Site
COMPLETED

Bialystok, 15-274, Poland
Research Site
WITHDRAWN

Krakow, 30-663, Poland
Research Site
COMPLETED

Lodz, 93-338, Poland
Research Site
RECRUITING

Warsaw, 02-097, Poland
Research Site
RECRUITING

Bucharest, 022322, Romania
Research Site
WITHDRAWN

Bucharest, 077120, Romania
Research Site
RECRUITING

Cluj-Napoca, 400370, Romania
Research Site
WITHDRAWN

Târgu Mureş, 540136, Romania
Research Site
RECRUITING

Timișoara, 300011, Romania
Research Site
WITHDRAWN

Samara, 443095, Russia
Research Site
RECRUITING

Esplugues de Llobregat, 08950, Spain
Research Site
RECRUITING

Madrid, 28041, Spain
Research Site
SUSPENDED

Dnipropetrovsk, 49100, Ukraine
Research Site
SUSPENDED

Kharkiv Region, 61075, Ukraine
Research Site
SUSPENDED

Kyiv, 04050, Ukraine
Research Site
WITHDRAWN

Odesa, 65038, Ukraine
Research Site
SUSPENDED

Sumy, 40031, Ukraine
Research Site
COMPLETED

Zaporizhzhia, 69063, Ukraine
Research Site
RECRUITING

Glasgow, G51 4TF, United Kingdom
Research Site
RECRUITING

Hampshire, SO16 6YD, United Kingdom
Research Site
COMPLETED

Manchester, M13 9WL, United Kingdom
Research Site
TERMINATED

Nottingham, NG7 2UH, United Kingdom

Conditions

Explore the condition pages connected to this study.

HYPERKALAEMIA